What is cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Cardiomyopathy?

Cardiomyopathy is a disease of the heart muscle characterized by structural and functional abnormalities that occur in the absence of coronary artery disease, hypertension, valvular disease, or congenital heart disease sufficient to explain the observed cardiac dysfunction 1, 2.

Core Definition and Pathophysiology

Cardiomyopathies represent a heterogeneous group of myocardial disorders where the heart muscle becomes structurally and functionally abnormal, leading to mechanical or electrical dysfunction 3. The key distinguishing feature is that these abnormalities cannot be explained by abnormal loading conditions (such as hypertension or valvular disease) or ischemic heart disease 4.

Classification Framework

The classification of cardiomyopathies has evolved significantly with advances in molecular genetics and imaging. Current classification systems recognize five major morphological and functional phenotypes 1, 5:

1. Dilated Cardiomyopathy (DCM)

  • Characterized by ventricular dilation and depressed myocardial performance
  • Represents a spectrum of heterogeneous myocardial disorders
  • Prevalence approximately 1:250 to 1:400 in the general population 4
  • Familial DCM accounts for 30-50% of cases, with 30-40% having identifiable genetic causes 4

2. Hypertrophic Cardiomyopathy (HCM)

  • Abnormally thickened ventricular myocardium without identifiable cause
  • Most commonly reported cause of sudden cardiac arrest in young athletes 5

3. Restrictive Cardiomyopathy

  • Normal to thickened ventricular walls with normal ventricular size
  • Impaired diastolic function, often with dilated atria 5

4. Arrhythmogenic Cardiomyopathy (ACM)

  • Includes arrhythmogenic right ventricular cardiomyopathy
  • Enlarged, dilated right ventricle (can affect left ventricle) with or without decreased systolic function
  • Associated with frequent arrhythmias 5

5. Unclassified Cardiomyopathies

  • Includes left ventricular noncompaction
  • Abnormal myocardium with hypertrabeculation 5

Primary vs. Secondary Cardiomyopathies

The American Heart Association divides cardiomyopathies into two major groups based on organ involvement 1:

  • Primary cardiomyopathies: Genetic, nongenetic, or acquired forms solely or predominantly confined to heart muscle
  • Secondary cardiomyopathies: Myocardial involvement as part of systemic multiorgan disorders including amyloidosis, hemochromatosis, sarcoidosis, autoimmune diseases, toxins, cancer therapy, and endocrine disorders like diabetes mellitus 1

Clinical Significance and Prognosis

Cardiomyopathies are the leading diagnosis for heart transplant patients worldwide 6. They often lead to progressive heart failure with significant morbidity and mortality 7. The presence of atrial fibrillation in cardiomyopathy patients portends increased risk for thromboembolism, heart failure progression, and cardiovascular mortality 2.

The overall prognosis varies by type but is generally serious—approximately 50% of patients are dead at 4 years, and 40% of patients admitted to hospital with heart failure are dead or readmitted within 1 year 8.

Epidemiology

In the United States, the age-adjusted prevalence of DCM is approximately 36 cases per 100,000 population (1:2500) 1. The prevalence of cardiomyopathy increases sharply with age, rising to 10-20% in 70- to 80-year-old individuals 8. Geographic variations exist, with higher prevalence in underdeveloped and tropical countries compared to developed nations 1.

Clinical Presentation

Early stages are often asymptomatic, but symptomatic patients present with classic heart failure manifestations 7:

  • Shortness of breath and dyspnea
  • Fatigue and exercise intolerance
  • Orthopnea and paroxysmal nocturnal dyspnea
  • Peripheral edema
  • Cough

Breathlessness, tiredness, and fatigue are characteristic symptoms, though these can be non-specific 8. Loss of skeletal muscle mass and strength represents a late manifestation 8.

Important Clinical Pitfalls

The term "nonischemic cardiomyopathy" is often used interchangeably with DCM in clinical practice, but this is imprecise—nonischemic cardiomyopathy can include conditions caused by volume or pressure overload (hypertension, valvular disease) that are not conventionally accepted under the definition of DCM 1.

Diagnosis of heart failure by clinical means alone is often inadequate, particularly in women, the elderly, and obese patients 8. This underscores the importance of objective diagnostic testing including echocardiography, cardiac magnetic resonance imaging, B-type natriuretic peptide levels, and electrocardiography 7, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.